Cristina Saura, MD, on Breast Cancer: Results from the LORELEI Trial
0 seconds of 0 secondsVolume 90%
Press shift question mark to access a list of keyboard shortcuts
Keyboard Shortcuts
Play/PauseSPACE
Increase Volume↑
Decrease Volume↓
Seek Forward→
Seek Backward←
Captions On/Offc
Fullscreen/Exit Fullscreenf
Mute/Unmutem
Decrease Caption Size-
Increase Caption Size+ or =
Seek %0-9
Cristina Saura, MD, on Breast Cancer: Results from the LORELEI Trial
Posted: Tuesday, September 12, 2017
Cristina Saura, MD, of Vall d’Hebron Institute of Oncology, discusses phase II study findings on neoadjuvant letrozole plus taselisib vs letrozole plus placebo in postmenopausal patients with ER+/HER2– early breast cancer.
